Posts

Showing posts with the label Science

Experimental implant restores Parkinson's patient's ability to walk, researchers say

Image
[ad_1] A new implant targeting Parkinson's disease has restored one man's ability to walk after 25 years of suffering from the disease, according to a study published in the journal  Nature Medicine on Monday. Marc Gauthier, 63, was diagnosed with Parkinson's at age 36 and experienced decreased locomotive functioning as the illness progressed. With help from the experimental, surgically implanted device, he is now able to walk over three miles without stopping, according to the study. "Getting into an elevator ... sounds simple. For me, before, it was impossible," Gauthier said in an interview with NeuroRestore , a Swiss research and treatment center that works to restore neurological functions. "I was skating, I was freezing. Now ... I have no problem," he added. Interview provided by .NeuroRestore. by NPG Press on YouTube Parkinson's is a brain disorder that results in degeneration of the nervous syst

Eli Lilly says FDA delays approval of Alzheimer's drug in surprise move

Image
[ad_1] Eli Lilly headquarters in Indianapolis, Indiana, US, on Wednesday, May 3, 2023. Eli Lilly & Co.'s shares climbed in early US trading after its experimental drug for Alzheimer's slowed the progress of the disease in a final-stage trial, paving the way for the company to apply for US approval. AJ Mast | Bloomberg | Getty Images Eli Lilly said Friday that the Food and Drug Administration has pushed back its approval decision deadline for the drugmaker's experimental Alzheimer's treatment donanemab in a surprise move. The agency plans to call a last-minute meeting of its outside advisors to further review the treatment's safety and efficacy in a late-stage trial, Eli Lilly said. The FDA has not disclosed the date of that meeting, so a potential approval would likely come after this month. The FDA was expected to decide whether to greenlight the medicine by the end of the first quarter. That deadline was already delayed from an expected approval last ye

Spinal cord stimulation can improve arm and hand motion after a stroke, study finds

Image
[ad_1] A study published in the medical journal Nature on Monday found that targeted electrical pulses delivered to the spinal cord can help improve arm and hand movement after a stroke. Two patients were able to regain additional motion in their arm and hand through a device implanted at the base of the spine, which delivered pulses in areas responsible for hand and arm function. The patients were able to regain temporarily the ability to grab and move objects, when they had been previously unable to do so, by strengthening signals to the brain that enable movement. Figure A Nature Medicine "We're not bypassing their control. We're enhancing their capabilities to move their own arm," Marco Capogrosso, one of the researchers who worked alongside a team at Carnegie Mellon University, told the Associated Press.

New Covid boosters could reach Americans as soon as Thursday – here's what you need to know

Image
[ad_1] A nurse prepares doses of the Pfizer vaccine during a COVID-19 vaccination event at Josephine's Southern Cooking in Chatham, Illinois, Dec. 30, 2021. Brian Cassella | Tribune News Service | Getty Images A new round of Covid vaccines is finally here in the U.S. The Centers for Disease Control and Prevention cleared single-strain shots from Pfizer and Moderna for all Americans six months and up on Tuesday, following approvals from the Food and Drug Administration on Monday. Those mRNA vaccines are designed to target a relatively new omicron subvariant called XBB.1.5 .  The first doses of the new shots will be available at some pharmacies and other vaccine distribution locations within 48 hours of the CDC's recommendation, agency staff said Tuesday during a meeting of independent advisors to the CDC. That means jabs could reach Americans as soon as Thursday. Meanwhile, the FDA is still reviewing a third updated vaccine from Novavax for people ages 12 and up.  Th

Harvard psychologist: If you use any of these 9 phrases every day, 'you're more emotionally resilient than most'

Image
[ad_1] Emotionally resilient people are deliberate in their response to painful experiences. They allow themselves to grieve, remind themselves of what they are grateful for, and focus on what they can control in the moment. But as a Harvard-trained psychologist , I've seen so many people struggle with this. It takes effort, practice and mental strength. If you use any of these phrases every day, you are more emotionally resilient than most: 1. "I can get through this." Emotional resilience is associated with grit and mental toughness. There is an understanding that we have to be strong and overcome adversity without letting it break us. Similar phrase: "As much as I hate this, I can survive it." 2. "I'm not going to let myself be a victim." Being resilient means that when you experience the pain of mistreatment, you shift your perspective from "I'm a victim and powerless to help myself" to "How can I grow from this?"

Medicare will pay for Alzheimer's drug Leqembi. What patients and doctors should know

Image
[ad_1] The Alzheimer's drug Leqembi is seen in this undated handout image obtained by Reuters on January 20, 2023. Eisai | via Reuters Medicare has agreed to pay for the Alzheimer's treatment Leqembi , a major turning point for patients who are diagnosed with the early stages of the disease. Leqembi is the only drug on the market right now that has demonstrated the ability to slow the progression of early stages of Alzheimer's disease in a clinical trial. The monoclonal antibody, administered twice monthly through intravenous means, slowed cognitive decline by 27% over 18 months in the trial. Leqembi is made by Japanese drugmaker Eisai and its partner Biogen , which is based in Cambridge, Massachusetts. Medicare's decision to cover Leqembi, which came moments after the Food and Drug Administration fully approved the drug Thursday, promises to make the treatment more accessible to patients. Medicare coverage is crucial for most patients to have any hope of being

High levels of a hazardous chemical polluted the air weeks after the Ohio train derailment, an analysis shows

Image
[ad_1] General view of the site of the derailment of a train carrying hazardous waste, in East Palestine, Ohio, March 2, 2023. Alan Freed | Reuters Soon after the  derailment of a Norfolk Southern  train in East Palestine, Ohio, a team of researchers began roving the small town in a Nissan van. It was February, less than three weeks after the disaster, and the van was outfitted with an instrument called a mass spectrometer, which can measure hundreds to thousands of compounds in the air every second. The team was searching for harmful levels of air pollution. At the time, a primary concern was a flammable substance called vinyl chloride, because Norfolk Southern intentionally burned off the chemical in an attempt to avoid the chance of an explosion. Some environmental health experts thought the chemical may have contributed to the  rashes, vomiting, bloody noses and bronchitis  some residents reported. But a  new study  from the team behind the research van — a group of scientist

UGC Urges Colleges, Universities to Register on Biological Research Regulatory Approval Portal

Image
[ad_1] As per UGC, it will give regulatory information to researchers and expedite approvals (Representative image) According to the UGC, it is a unique digital gateway designed to increase access to science and scientific research as well as make it simpler to establish businesses The University Grants Commission (UGC) has ordered that higher educational institutions (HEIs) and their affiliated colleges/institutions register on the Biological Research Regulatory Approval Portal (BioRRAP), biorrap.gov.in. The Government of India established the Biological Research Regulatory Approval Portal (BioRRAP) to give regulatory information to researchers and expedite approvals. According to the UGC, it is a unique digital gateway designed to increase access to science and scientific research as well as make it simpler to establish businesses. BioRRAP is anticipated to incorporate information on foreign research projects that have been approved by all line Ministries/Departments of the Gov

Space Force raises the stakes as rocket companies compete for lucrative military missions

Image
[ad_1] A Falcon Heavy rocket launches the USSF-67 mission on January 15, 2023 from NASA's Kennedy Space Center in Florida. SpaceX The U.S. military is raising the stakes — and widening the field — on a high-profile competition for Space Force mission contracts. The Space Force plans to buy even more rocket launches from companies in the coming years than previously expected, granting more companies a chance at securing billions in potential contracts. "This is a huge deal," Col. Doug Pentecost, the deputy program executive officer of the U.S. Space Force's Space Systems Command, told reporters during a briefing this week. Earlier this year the Space Force kicked off the process to buy five years' worth of launches, under a lucrative program known as National Security Space Launch (NSSL) Phase 3. Now it's boosting the scale. The U.S. sees a rising impetus to improve its military capabilities in space, spurring the need to almost triple the number of launch

Pfizer Group B strep vaccine for infants returns encouraging mid-stage trial results

Image
[ad_1] Streptococcus agalactiae bacteria, responsible for vaginal and urinary tract infections and newborn infections including meningitis and septicemia. Optical microscopy view. Cavallini James | BSIP | Universal Images Group | Getty Images Pfizer on Wednesday said its experimental vaccine targeting the potentially deadly bacterial disease Group B Streptococcus returned strong mid-stage clinical trial results , a promising step as the drug inches toward potential approval. Pfizer is among several drugmakers racing to develop the world's first shot targeting Group B strep disease, which is linked to nearly 150,000 infant deaths worldwide each year, especially in lower-income countries. The Food and Drug Administration in September granted breakthrough therapy designation to Pfizer's vaccine, which is intended to expedite the development and review of the shot.  Pfizer's single-dose shot generated antibodies that may provide infants with meaningful protection aga

FDA says soda sweetener aspartame is safe, disagreeing with WHO finding on possible cancer link

Image
[ad_1] Cans of PepsiCo's Pepsi Zero Sugar soda are displayed for an arranged photograph taken in Tiskilwa, Illinois, on Wednesday, April 17, 2019. Daniel Acker | Bloomberg | Getty Images The U.S. Food and Drug Administration disagrees with a World Health Organization finding that the widely used soda sweetener aspartame possibly causes cancer in humans, saying the studies used to reach that conclusion had "significant shortcomings." "Aspartame is one of the most studied food additives in the human food supply. FDA scientists do not have safety concerns when aspartame is used under the approved conditions," an agency spokesperson said late Thursday shortly after the WHO released its findings. The International Agency for Research on Cancer, a WHO body, found a possible link between aspartame and a type of liver cancer called hepatocellular carcinoma after reviewing three large human studies in the U.S. and Europe. Aspartame is used as a substitute for sugar

WHO says soda sweetener aspartame may cause cancer, but it's safe within limits

Image
[ad_1] A can of Diet Coke in a supermarket, as an artificial sweetener commonly used in thousands of products including diet fizzy drinks, ice cream and chewing gum is to be listed as posing a possible cancer risk to humans, according to reports. Yui Mok | Pa Images | Getty Images The World Health Organization on Thursday classified the soda sweetener aspartame as a possible carcinogen, but said it is safe for people to consume within the recommended daily limit. The International Agency for Research on Cancer, a WHO body, identified a possible link between aspartame and a type of liver cancer called hepatocellular carcinoma after reviewing three large human studies conducted in the U.S. and Europe that examined artificially sweetened beverages. related investing news Aspartame is used in Diet Coke, Pepsi Zero Sugar and other diet sodas , as well as some chewing gum and various Snapple drinks as a substitute for sugar. Artificially sweetened beverages have historically been the bi